MSB 0.93% $1.09 mesoblast limited

Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-129

  1. 6,869 Posts.
    lightbulb Created with Sketch. 1265
    The hope is a partnership. Like what we thought was Novartis. But real!

    It's a different disease and this time there is P3 data to look at whilst embarking on a new one and the FDA seems to be shining a torch on the path (somewhat).

    MSB's 'hand' in negotiating the deal for this one is now heavily weighted towards their benefit.

    The upside (maybe) is the world knows SI has a massive set of testicles so don't even bother if the money isn't right!! Or his unique conditions (whatever the hell they are - I have guessed previously).

    Whispers in the wind will be at an all time high now I reckon. By the looks of the SP movements in advance of the announcements recently, the whispers started a few days ago.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
0.010(0.93%)
Mkt cap ! $1.244B
Open High Low Value Volume
$1.07 $1.10 $1.05 $4.880M 4.545M

Buyers (Bids)

No. Vol. Price($)
2 54894 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 24700 1
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
$1.09
  Change
0.010 ( 0.40 %)
Open High Low Volume
$1.07 $1.10 $1.05 1011230
Last updated 15.59pm 17/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.